325 related articles for article (PubMed ID: 24723647)
1. Update of the European guidelines for basal cell carcinoma management.
Trakatelli M; Morton C; Nagore E; Ulrich C; Del Marmol V; Peris K; Basset-Seguin N;
Eur J Dermatol; 2014; 24(3):312-29. PubMed ID: 24723647
[TBL] [Abstract][Full Text] [Related]
2. [What is new in basal cell carcinoma?].
Heppt M; von Braunmühl T; Berking C
Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
[TBL] [Abstract][Full Text] [Related]
3. Guidelines of care for the management of basal cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olencki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):540-559. PubMed ID: 29331385
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma-treatments for the commonest skin cancer.
Berking C; Hauschild A; Kölbl O; Mast G; Gutzmer R
Dtsch Arztebl Int; 2014 May; 111(22):389-95. PubMed ID: 24980564
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of basal cell carcinoma].
Schmitz L; Dirschka T
Hautarzt; 2016 Jun; 67(6):483-99. PubMed ID: 27206448
[TBL] [Abstract][Full Text] [Related]
6. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
Peris K; Fargnoli MC; Kaufmann R; Arenberger P; Bastholt L; Seguin NB; Bataille V; Brochez L; Del Marmol V; Dummer R; Forsea AM; Gaudy-Marqueste C; Harwood CA; Hauschild A; Höller C; Kandolf L; Kellerners-Smeets NWJ; Lallas A; Leiter U; Malvehy J; Marinović B; Mijuskovic Z; Moreno-Ramirez D; Nagore E; Nathan P; Stratigos AJ; Stockfleth E; Tagliaferri L; Trakatelli M; Vieira R; Zalaudek I; Garbe C;
Eur J Cancer; 2023 Oct; 192():113254. PubMed ID: 37604067
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
8. Treatment of basal cell carcinoma in Scandinavia: evidence or eminence based?
Helsing P; Gjersvik P; Tarstedt M
Int J Dermatol; 2015 Sep; 54(9):1030-3. PubMed ID: 25660368
[TBL] [Abstract][Full Text] [Related]
9. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
10. [Basal cell carcinoma].
Takenouchi T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Basal Cell Carcinoma.
Tanese K
Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
[TBL] [Abstract][Full Text] [Related]
12. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.
Correia de Sá TR; Silva R; Lopes JM
Future Oncol; 2015 Nov; 11(22):3023-38. PubMed ID: 26449265
[TBL] [Abstract][Full Text] [Related]
14. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
15. The effective treatment of basal cell carcinoma.
Skelton LA
Br J Nurs; 2009 Mar 26-Apr 8; 18(6):346, 348-50. PubMed ID: 19329898
[TBL] [Abstract][Full Text] [Related]
16. European Dermatology Forum Guidelines on topical photodynamic therapy.
Morton C; Szeimies RM; Sidoroff A; Wennberg AM; Basset-Seguin N; Calzavara-Pinton P; Gilaberte Y; Hofbauer G; Hunger R; Karrer S; Lehmann P; Piaserico S; Ulrich C; Braathen L;
Eur J Dermatol; 2015; 25(4):296-311. PubMed ID: 26065545
[TBL] [Abstract][Full Text] [Related]
17. Face and Scalp Basal Cell Carcinoma Treatment: A Review of the Literature.
Bernardini N; Skroza N; Zuber S; Tolino E; Balduzzi V; Mambrin A; Marchesiello A; Anzalone A; Colapietra D; Proietti I; Potenza C
Acta Dermatovenerol Croat; 2019 Mar; 27(1):22-27. PubMed ID: 31032787
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
[TBL] [Abstract][Full Text] [Related]
19. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
20. Current diagnosis and treatment of basal cell carcinoma.
Alter M; Hillen U; Leiter U; Sachse M; Gutzmer R
J Dtsch Dermatol Ges; 2015 Sep; 13(9):863-74; quiz 875. PubMed ID: 26882375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
